CClinicalTrials.gg
CompletedNCT07299669BEMER-sportUpdated Jan 6, 2026

Effects of BEMER Electromagnetic Field Intervention on Sleep, Readiness to Play and Injuries in Elite Athletes

An interventional study of BEMER electromagnetic-energy-regulation therapy and Sham (No Treatment) in Fatigue Recovery, sponsored by University of Bergen. Completed at 2 sites in Norway. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-06.

Sponsored by University of Bergen · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jan 2025, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Elite athletes (female football players) will be randomized to 1 of 2 conditions, comprising a BEMER electromagnet field mattress and a sham-mattress. The mattress is to be used in bed for 8 minutes each morning, and for 8 minutes each evening, for 10 weeks. The system has 3 intensity levels - low, medium, and high. The low level will be used for the 4 first weeks, the medium level for the following 2 weeks, and the high level for the last 4 weeks. Those in the sham conditions have a display and mattress looking identical, and follow the same procedure as those in BEMER electromagnet field mattress condition. The primary outcome comprises total sleep time and sleep efficacy assessed with a sleep radar as well as readiness to play (composite measure of daily self-report of fatigue, sleep quality, muscle soreness, stress and mood). Secondary outcomes comprise duration of deep sleep also assessed with the sleep radar, injury severity, and rate of perceived exertion following training and matches. Baseline registrations are conducted for 4 weeks prior to the intervention and outcomes are registered during the last 4 weeks of the intervention.

Read the detailed description

Contrary to common assumptions, athletes often experience insufficient sleep, particularly in the context of competitive events. Furthermore, a significant proportion of athletes report poor sleep quality, potentially linked to frequent travel, intense training, suboptimal training times and inadequate caloric intake. Female athletes are especially susceptible, facing additional challenges such as role conflicts, gender discrimination, body image concerns, increased risk of eating disturbances, and negative impact from menstruation, all of which may hinder restitution. A promising intervention to enhance and facilitate restitution involves the use of low frequency pulsed electromagnetic field (PEMF) therapy, which has demonstrated the potential to increase blood flow, particularly in micro vessels, and is as such assumed to increase micro-circulation, among other in the skeleton muscles. The effectiveness of PEMF therapy in athletes has so far not been investigated using a randomized controlled design.

In this study, a triple blind (participants, researchers and statistician) randomized controlled trial will be undertaken, with female athletes (N=60) from national (Norway) football teams being randomly designed to receive either a placebo mattress or a PEMF-mattress based on a 1:1 ratio, using stratified randomization by team. During a baseline assessment period of 4 weeks, 3 primary outcomes (radar assessed total sleep time and sleep efficiency), and readiness to play (composite measure of daily self-report of fatigue, sleep quality, muscle soreness, stress and mood) will be recorded at a daily basis. These 3 outcomes will be analyzed also specifically for the day/night following matches (as secondary outcomes). Other secondary outcomes comprise the amount (duration) of slow wave sleep/deep, assessed with the sleep radar technology, the severity of injuries, and the rate of perceived exertion (RPE) following training and matches.

The participants (N=60) will following the 4-week baseline registration commence a 10 week intervention phase involving daily use of the mattress for 2 (morning and evening) x 8 minutes. The system has 3 levels of PEMF-intensity (low, medium, high). The first four weeks the low intensity will be used, the next two the medium intensity will be used, thereafter (last four weeks) the high intensity will be used. This intervention period will be accompanied by reassessment of the primary and secondary outcomes during the last 4 weeks of the 10-week intervention period.

02

Conditions studied

  • Fatigue Recovery

Browse trials for

Keywords

  • BEMER
  • Athletes
  • Recovery
  • Sleep
  • Injury
  • Readiness to play
  • Rate of perceived exertion
03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.

This study's enrollment of 60 is above the median of 52 across 3,239 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

University of Bergen is the lead sponsor of 141 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Minimum 18 years of age
  • Female elite football player in Norway
  • Playing on team willing to part-take in the study

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    BEMER electromagnetic-energy-regulation therapy

    BEMER electromagnetic mattress; week 1-4 at low lever, week 5-6 medium level and week 7-10 high level

    Device: BEMER electromagnetic-energy-regulation therapy

  • Sham comparator
    Sham-mattress

    Mattress and interface panel similar to the experimental intervention, but without any electromagnetic output signals

    Device: Sham (No Treatment)

Interventions

  • DeviceBEMER electromagnetic-energy-regulation therapy

    The BEMER is bio-electric-magnetics-energy-regulation therapy uses a specific waveform of pulsed electromagnetic field (PEMF) to improve microcirculation by 30%. In the present study the bio-electric-magnetics-energy-regulation therapy will be provided through mattresses

    Also known as: BEMER

  • DeviceSham (No Treatment)

    Sham mattress with no electromagnetic output

06

What researchers measure

Primary outcomes

  1. Total sleep time

    Total sleep time in the main sleep episode assessed with the sleep radar Somnofy, expressed as minutes per day. High total sleep time is regarded as a more positive outcome than a lower total sleep time.

    Time frame: Change from baseline (4 weeks before interventions) to the last 4 weeks of the intervention.

  2. Sleep efficiency

    Percentage of time in bed following shut-eye (lights out) to rising from bed where the participant did sleep - assessed with the sleep radar Somnofy during the main sleep period. The measure comprises the percentage of time being asleep, and higher values (percentage) are regarded as a better outcome than lower values (percentage).

    Time frame: Change from baseline (4 weeks before intervention) to the last 4 weeks of the intervention

  3. Readiness to play

    Daily morning self-report on an adapted version of the Hooper Index (Hooper, Mackinnon, Howard, Gordon, \& Bachmann, 1995), comprising four items assessing fatigue, sleep quality, muscle soreness, and stress. Each item is rated on a 7-point scale ranging from 1 to 7 (where 7 is the worst state and 1 is the best state). A composite daily score ranging from 4 to 28 is calculated - lower scores are associated with the best outcomes.

    Time frame: Change from baseline (4 weeks before intervention) to the last 4 weeks of the intervention

Secondary outcomes

  1. Total sleep time the day following matches

    Total sleep time in the main sleep episode assessed with the sleep radar Somnofy the day following matches, expressed as minutes per day. High total sleep time is regarded as a more positive outcome than a lower total sleep time.

    Time frame: Change from baseline (4 weeks before interventions) to the last 4 weeks of the intervention exclusively on the nights after matches.

  2. Sleep efficiency the day following matches

    Percentage of time in bed following shut-eye (lights out) to rising from bed where the participant did sleep assessed with the sleep radar Somnofy during the main sleep period - the day following matches. The measure comprises the percentage of time being asleep, and higher values (percentage) are regarded as a better outcome than lower values (percentage).

    Time frame: Change from baseline (4 weeks before intervention) to the last 4 weeks of the intervention exclusively the night following matches.

  3. Readiness to play the day after matches

    Daily morning self-report on an adapted version of the Hooper Index (Hooper, Mackinnon, Howard, Gordon, \& Bachmann, 1995), comprising four items assessing fatigue, sleep quality, muscle soreness, and stress. Each item is rated on a 7-point scale ranging from 1 to 7 (where 7 is the worst state and 1 is the best state). A composite daily score ranging from 4 to 28 is calculated - lower scores are associated with the best outcomes.

    Time frame: Change from baseline (4 weeks before intervention) to the last 4 weeks of the intervention, exclusively on the day after matches.

  4. Deep sleep duration

    Deep sleep duration assessed with the sleep radar Somnofy during the main sleep period, expressed in minutes. Higher values are regarded as better outcomes than lower values

    Time frame: Change from baseline (4 weeks before intervention) to the last 4 weeks of the intervention

  5. Health problems

    Health problems are assessed with the Oslo Sports Trauma Research Center Questionnaire on Health Problems-2. The questionnaire has four items (degree of health problem impact on: 1) participation in training, 2) modification of training, 3) performance, and 4) pain). All items have four response alternatives and each is scored 0-8-17-25. A composite score ranging from 0-100 is calculated - higher numbers reflect higher health problem severity. The instrument will be administered once per week.

    Time frame: Change from baseline (4 weeks before interventions) to the last 4 weeks of the intervention.

  6. Rate of perceived exertion

    Rate of Perceived Exertion (RPE) following training and matches as measured by a single item based on the Borg CR-10 scale (Borg, 1990). The response alternatives ranges from 0 (no exertion) to 10 (maximal exertion). Lower values are regarded as better outcomes than higher values.

    Time frame: Change from baseline (4 weeks before interventions) to the last 4 weeks of the intervention.

07

Study locations

2 sites
  • Bergensregionen
    Bergen, Norway
  • Osloregionen
    Oslo, Norway
08

References and documents

Individual participant data

Plan to share: Yes — Complete dataset

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07299669
Lead sponsor
University of Bergen
Collaborators
Western Norway University of Applied Sciences, Norwegian University of Science and Technology
Responsible party
Ståle Pallesen (Professor, University of Bergen) — Principal investigator
First posted
Dec 23, 2025
Start date
Jan 18, 2025
Primary completion
Oct 15, 2025
Completion
Oct 15, 2025
Last update
Jan 6, 2026

Study contacts

Ståle Pallesen, PhD
principal investigator · University of Bergen

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion